key: cord-0914715-x9x0nhze
authors: Pierros, V.; KONTOPODIS, E.; STRAVOPODIS, D. J.; TSANGARIS, G. T.
title: Prediction of SARS-CoV-2 Omicron Variant Immunogenicity, Immune Escape and Pathogenicity, through Analysis of Spike Protein-specific Core Unique Peptides
date: 2021-12-29
journal: nan
DOI: 10.1101/2021.12.26.21268418
sha: 23fc42c2c97706fb275d0a4576c1292237c0bda1
doc_id: 914715
cord_uid: x9x0nhze

The recently discovered Omicron variant of the SARS-CoV-2 corona virus has raised a new, global, awareness, since it is considered as a new variant of concern from all major health organizations, including WHO and ECDC. Omicron variant is characterized by 30 amino acid changes, three small deletions and one small insertion in the Spike protein. In this study, we have identified the Core Unique Peptides (CrUPs) that reside exclusively in the Omicron variant of Spike protein and are absent from the human proteome, thus creating a new dataset of peptides named as C/H-CrUPs. Furthermore, we have analyzed their protein locations and compared them with the respective ones of Alpha and Delta SARS-CoV-2 variants. In Omicron, 115 C/H-CrUPs were generated and 119 C/H-CrUPs were lost, almost four times as many compared to the other two variants. From position 440 to position 508, at the Receptor Binding Motif (RBM), 8 mutations were detected, resulting in the construction of 28 novel C/H-CrUPs. Most importantly, in Omicron variant, new C/H-CrUPs carrying two or three mutant amino acids were produced, as a consequence of the accumulation of multiple mutations in the RBM. Remarkably, these Omicron-derived C/H-CrUPs that bear several mutated amino acids could not be recognized in any other viral Spike variant. We suggest that virus binding to the ACE2 receptor is facilitated by the herein identified C/H-CrUPs in contact point mutations and Spike-cleavage sites, while the immunoregulatory NF9 peptide is not detectably affected. Taken together, our findings indicate that Omicron variant contains intrinsic abilities to escape immune-system attack, while its mutations can mediate strong viral binding to the ACE2 receptor, leading to highly efficient fusion of the virus to the target cell. However, the intact NF9 peptide suggests that Omicron exhibits reduced pathogenicity compared to Delta variant.

SARS-CoV-2 virus has been presented with an ability of high mutagenesis frequency, hitherto producing 63 different variants with 39 of them being considered as the most predominant forms, including Delta, the dominant variant of the 4 th pandemic wave (1) . Recently, a new variant, the Omicron (B.1.1.529), was identified in South Africa. Omicron is characterized by 30 amino acid changes, three small deletions and one small insertion in Spike protein, as compared to the original virus, with 15 of them residing in the Receptor Binding Domain (RBD) from 319 to 541 amino acid residues (2). To elucidate the SARS-CoV-2 virus-host organism interactions, we have designed a novel bioinformatics approach to analyze the Core Unique Peptides (CrUPs) of the SARS-CoV-2 virus against the human proteome (C/H-CrUPs) (1) . C/H-CrUPs represent a completely new set of peptides, which are the sortest in length peptides in viral proteome that do not exist in human proteome. Based on their properties, the viral C/H-CrUPs could advance our knowledge regarding virus-host interactions, immune-system response(s), infectiveness and pathogenicity of the virus, while, most importantly, they can be used as antigenic and diagnostic peptides, and likely druggable targets for successful therapeutic treatments. In the present study, we have identified, cataloged and analyzed the Omicron-specific C/H-CrUPs, in order to illuminate the mechanisms controlling infectivity, immune escape and pathogenicity of the new variant.

For our recent studies (1, 3), we have developed a bioinformatics tool that can extract from a given proteome the Core Unique Peptides (CrUPs) (thus creating its Uniquome) (Supp. Fig. 1 ). We have expanded this tool by introducing a new feature that can extract the CrUPs of each individual protein of a given proteome (target) versus the proteins of a reference proteome. This new feature, like the initial implementation, will split each protein in the target proteome to all possible peptides of length minimum (4 amino acids) to length maximum (100 amino acids) and search them against the reference proteome. Each search will exclude all peptides that contain a smaller peptide already identified as CrUP (Supp. Fig. 2 ).

For the present study, we have engaged this new feature of our tool. We have created a "custom" proteome consisting of sequences from all variants of the SARS-CoV-2 Spike proteins and used it as the target versus the human proteome. The tool produces as output the C/H-CrUPs per protein of the target proteome, thus revealing the CrUPs for each Spike variant versus the human proteome.

Once we have the desired data, we run a meta-analysis to identify how many C/H-CrUPs remain the same, or are added or lost on each variant versus the wild-type Spike protein. For this analysis, initially we take the identified C/H-CrUPs of the wild-type sequence and check their presence against the respective C/H-CrUPs of the other variants. We only care for the amino acid sequence and not the position this could be found within the protein. If the sequence is found, then we consider the peptide to be the same, otherwise we consider it to be lost on the examined variant. predominant variants of the virus in human populations. Hence, it proved that, in contrast to Alpha and Delta variants, at the end of Omicron variant RBM area, from 440 to 508 amino acid position, 8 novel mutations were identified, resulting in production of 28 new C/H-CrUPs. The most important finding is that in Omicron variant, for the first time, new C/H-CrUPs including two or three mutant amino acids were generated, with the peptides "QAGN*K*P", "N*K*PCN", "LK*SYS*F" and "K*SYS*FR*" being characteristic examples, as a result of the accumulation of multiple mutations in the positions 440, 446, 477, 478 and 493-505. These novel C/H-CrUPs that contain several mutated amino acids could not be found in any other virus variants till today. Taking into consideration recent data about virus infectivity, the multimutated, new, C/H-CrUP collection seems to change radically the structure and the epitope regions of end positions of the RBM area, in Omicron variant, causing serious compromise of its antigenic capacity and facilitating the immune escape of the virus (9). Remarkably, RBM area contains 11 out of the 12 contact points of viral Spike protein with the ACE2 cellular receptor. Among them, 7 contact points remained intact, while 4 mutations in positions Q493K, Q498R, N501Y and Y505H were identified, resulting in the construction of 17 new C/H-CrUPs (Table 3) . N501Y mutation was found to be a major determinant of increased viral transmission, due to improved binding affinity of Spike protein to ACE2 cellular receptor (12) . These findings indicate that virus binding to ACE2 receptor is notably affected by C/H-CrUP-specific mutations that can likely strengthen the Spike-ACE2 protein-protein interaction(s). Interestingly, an important amino acid sequence in RBM area is the "NYNYLYRLF" peptide (from 448 to 456 position). This Tyrosine (Y)-enriched peptide carries two contact sites (Y449 and Y453) and it is known as the NF9 peptide (10) . It seems to affect antigen recognition, by being an immunodominant HLA*24:02-restricted epitope identified by CD8 + T cells. Of note, NF9 presents immune stimulation activity, and increases cytokine production derived from CD8 + T cells, such as IFN-γ, TNF-α and IL-2 (11) . In contrast to Delta, in Omicron variant the NF9 amino acid content is not changed by any mutation detected, thus suggesting that the NF9 peptide could induce an early immune system activation and efficient cytokine production, leading to a faster immune response, and thus reducing SARS-CoV-2 virus pathogenicity.

The molecular mechanism of Spike protein's proteolytic activation has been shown to play a crucial role in the selection of host species, virus-cell fusion, and viral infection of human lung cells (13) (14) (15) . Spike protein [SPIKE_SARS2 (P0DTC2)] contains three cleavage sites (known as S-cleavage sites) crucial for the virus fusion to the host cell: the R 685 ↓ S and R 815 ↓ S positions that serve as direct targets of the Furin protease, and the T 696 ↓ M position that can be recognized by the TMPRSS2 protease (16) (17) (18) . In these cleavage sites Omicron variant carries only the critical mutation P681H, which also appears in the Alpha variant (Fig. 1B) . Strikingly, in contrast to Delta variant, which contains the P681R mutation, the P681H mutation constructs several new C/H-CrUPs in the Alpha and Omicron variants, thus indicating their dispensable contribution to virus fusion to the host cell (Table 4 ). All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted December 29, 2021. ; https://doi.org/10.1101/2021.12.26.21268418 doi: medRxiv preprint

Analysis of C/H-CrUP landscapes in heavily mutated SARS-CoV-2 Omicron variant Spike protein unveiled that the Omicron variant, by the generation of novel multimutated C/H-CrUPs could escape the immune system defense mechanisms, while these C/H-CrUP-specific mutations could facilitate the more efficient virus binding to the ACE2 cellular receptor, and to the more productive fusion of the virus to the host cell. Most importantly, in contrast to Delta variant, in Omicron variant the intact NF9 peptide, which has a known immunostimulatory effect, suggests that Omicron variant exhibits reduced pathogenicity, as compared to the Delta one. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. e  p  r  o  t  e  i  n  C  /  H  -C  r  U  P  s  a  c  r  o  s  s  v  a  r  i  a  n  t  s  ,  a  s  c  o  m  p  a  r  e  d  t  o  t  h  e  w  i  l  d  -t  y  p  e  v  i  r  u  s  r  e  s  p  e  c  t  i  v  e  s  e  q  u  e  n  c  e   V  a  r  i  a  n  t  C  /  H  -C preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. T  a  b  l  e  2  .   C  /  H  -C  r  U  P  s  c  o  n  s  t  r  u  c  t  e  d  a  r  o  u  d  t  h  e  m  u  t  a  t  i  o  n  s  i  n  R  B  D  o  f  A  l  p  h  a  ,  D  e  l  t  a  a  n  d  O  n  i  c  r  o  n  S  A  R  S  -C  o  V  2  v  a  r  i  a  n  t  s   C  /  H  -C  r  U  P  P  o  s  i  s  t  i  o  n  M  u  t  a  t  i  o  n  N  e  w  C  /  H  -C  r  U  P  s  P  o  s  i  s  t  i  o  n  C  /  H  -C  r  U  P  P  o  s  i  s  t  i  o  n  M  u  t  a  t  i  o  n  N  e  w  C  /  H  -C  r  U  P  s  P  o  s  i  s  t  i  o  n  C  /  H  -C  r  U  P  P  o  s  i  s  t  i  o  n  M  u  t  a  t  i  o  n  N  e  w  C  /  H  -C  r  U  P  s  P  o  s  i  s  t  i  o  n   G  N  Y  N  Y  L  4  4  7  G  N  Y  N  Y  R  4  4  7  P  G  Q  T  G  K  I  4  1  2  N  L  C  P  F  G  3  3  4  N  L  C  P  F  D  3  3  4  N  Y  N  Y  L  Y  4  4  8  G  Q  T  G  K  I  A  4  1  3  G  Q  T  G  N  I  4  1  3  L  C  P  F  G  E  3  3  5  L  C  P  F  D  E  3  3  5  Y  N  Y  R  Y  4  4  9  Q  T  G  N  I  A  4  1  4  P  F  G  E  V  F  3  3  7  P  F  D  E  V  3  3 T  a  b  l  e  3  .   C  /  H  -C  r  U  P  s  a  r  o  u  n  d  S  A  R  S  -C  o  V  -2  R  B  D  c  o  n  t  a  t  c  s  p  o  s  i  t  i  o  n  s   W  I  L  D  -T  Y  P  E  O  M  I  C  R  O  N  V  A  R  I  A  N  T   C  /  H  -C  r  U  P  s  N  e  w  c  o  n  s  t  r  u  c  t  e  d  C  /  H  -C  r  U The C/H-CrUPs around the mutant positions of Spike protein cleavages sites were presented. ↓ indicates the protein cleavage position.

All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted December 29, 2021. ; https://doi.org/10.1101/2021.12.26.21268418 doi: medRxiv preprint

Unique Peptide Signatures of SARS-CoV-2 Against Human Proteome Reveal Variants' Immune Escape and Infectiveness

SARS-CoV-2 Variant Prediction and Antiviral Drug Design are Enabled by RBD in vitro Evolution

Defining Variant-resistant Epitopes Targeted by SARS-CoV-2 Antibodies: A Global Consortium Study

Infectivity, Vaccine Breakthrough, and Antibody Resistance. ArXiv

SARS-CoV-2 Spike L452R Variant Evades Cellular Immunity and Increases Infectivity

SARS-CoV-2-specific CD8+ T Cell Responses in Convalescent COVID-19 Individuals

The N501Y Spike Substitution Enhances SARS-CoV-2 Infection and Transmission

The Furin Cleavage Site in the SARS-CoV-2 Spike Protein is Required for Transmission in Ferrets

SARS-CoV-2 Spike and its Adaptable Furin Cleavage Site

Cell Entry Mechanisms of SARS-CoV-2

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and is Blocked by a Clinically Proven Protease Inhibitor

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 is Essential for Infection of Human Lung Cells

Proteolytic Activation of SARS-CoV-2 Spike Protein

Competing interests: Authors declare that they have no competing interests. Data and materials availability: All data are available in the main text or in the supplementary materials.